Showing results (2531-2540 of 2,558) with videos related to
Sort By:
Pageof 256
Hepatology (Baltimore, Md.)|February 28, 2007
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicityChristine S Rollier, Glaucia Paranhos-Baccala, Ernst J Verschoor, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.The American Journal of Gastroenterology|March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver DiseaseNaim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.Hepatology Communications|February 5, 2024
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statementHannes Hagström, Leon A Adams, Alina M Allen, et al.Cancers|August 26, 2023
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD DatabaseFang-Shu Ou, Daniel H Ahn, Jesse G Dixon, et al.Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.Cancer Cell|March 28, 2025
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignanciesIoanna Mosialou, Abdullah M Ali, Rossella Labella, et al.European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD GroupKaitlyn K H Goey, Halfdan Sørbye, Bengt Glimelius, et al.Injury|September 22, 2020
Avoiding Cribari gridlock 2: The standardized triage assessment tool outperforms the Cribari matrix method in 38 adult and pediatric trauma centersJacob W Roden-Foreman, Nakia R Rapier, Michael L Foreman, et al.Pageof 256